Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 3
1976 12
1977 7
1978 12
1979 23
1980 17
1981 14
1982 32
1983 27
1984 5
1985 22
1986 15
1987 26
1988 25
1989 37
1990 34
1991 26
1992 17
1993 12
1994 5
1995 9
1996 1
1997 4
1998 4
1999 3
2000 3
2001 4
2002 2
2003 5
2004 1
2005 2
2006 5
2007 6
2008 5
2009 2
2010 3
2011 7
2012 7
2013 6
2014 6
2015 5
2016 7
2017 3
2018 6
2019 8
2020 8
2022 4
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

482 results
Results by year
Filters applied: . Clear all
Page 1
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
Easterling T, Mundle S, Bracken H, Parvekar S, Mool S, Magee LA, von Dadelszen P, Shochet T, Winikoff B. Easterling T, et al. Lancet. 2019 Sep 21;394(10203):1011-1021. doi: 10.1016/S0140-6736(19)31282-6. Epub 2019 Aug 1. Lancet. 2019. PMID: 31378394 Free PMC article. Clinical Trial.
However, the primary outcome did not differ between the nifedipine and labetalol groups (249 [84%] women vs 228 [77%] women; p=0.05) or the labetalol and methyldopa groups (p=0.80). ...As single drugs, nifedipine retard use resulted in a greater frequency of primary …
However, the primary outcome did not differ between the nifedipine and labetalol groups (249 [84%] women vs 228 [77%] women; p=0.05) …
Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
Rezk M, Emarh M, Masood A, Dawood R, El-Shamy E, Gamal A, Badr H. Rezk M, et al. Hypertens Pregnancy. 2020 Nov;39(4):393-398. doi: 10.1080/10641955.2020.1791902. Epub 2020 Jul 22. Hypertens Pregnancy. 2020. PMID: 32697618 Clinical Trial.
OBJECTIVE: to assess the maternal and fetal outcome in women with mild to moderate chronic hypertension on antihypertensive drug (methyldopa or labetalol) therapy compared to no medication. METHODS: This multicenter randomized clinical study was conducted at Menoufia Unive …
OBJECTIVE: to assess the maternal and fetal outcome in women with mild to moderate chronic hypertension on antihypertensive drug (methyldopa …
IV labetalol and oral nifedipine in acute control of severe hypertension in pregnancy-A randomized controlled trial.
Zulfeen M, Tatapudi R, Sowjanya R. Zulfeen M, et al. Eur J Obstet Gynecol Reprod Biol. 2019 May;236:46-52. doi: 10.1016/j.ejogrb.2019.01.022. Epub 2019 Mar 5. Eur J Obstet Gynecol Reprod Biol. 2019. PMID: 30878897 Clinical Trial.
RESULTS: Sixty women were randomised to each group and none were lost to follow-up. None of the patients in nifedipine group required labetalol, whereas three patients in labetalol group achieved target BP only after receiving nifedipine was administered after the m …
RESULTS: Sixty women were randomised to each group and none were lost to follow-up. None of the patients in nifedipine group required lab …
Lipid profile and cytokines in hypertension of pregnancy: A comparison of preeclampsia therapies.
Wang Y, Shi D, Chen L. Wang Y, et al. J Clin Hypertens (Greenwich). 2018 Feb;20(2):394-399. doi: 10.1111/jch.13161. Epub 2018 Jan 6. J Clin Hypertens (Greenwich). 2018. PMID: 29316154 Free PMC article. Clinical Trial.
The efficacy and safety of oral nifedipine (n = 71) and intravenous labetalol (n = 72) for the treatment of severe preeclampsia were evaluated in the next study according to maternal and neonatal outcomes. The levels of lipid profile and cytokines were linked with the pres …
The efficacy and safety of oral nifedipine (n = 71) and intravenous labetalol (n = 72) for the treatment of severe preeclampsia were …
Comparison of intravenous labetalol and hydralazine for severe hypertension in pregnancy in Northeastern Nigeria: A randomized controlled trial.
Muhammad S, Usman H, Dawha YM, Yahya A, Yekeen A, Bako B. Muhammad S, et al. Pregnancy Hypertens. 2022 Aug;29:1-6. doi: 10.1016/j.preghy.2022.05.001. Epub 2022 May 8. Pregnancy Hypertens. 2022. PMID: 35605426 Clinical Trial.
RESULTS: One hundred and thirteen patients' data were analyzed (fifty-six [56] in the hydralazine group and fifty-seven [57] in the labetalol group). There were no significant differences in the fall of the mean arterial blood pressure (labetalol; 24.19 mmHg/hydrala …
RESULTS: One hundred and thirteen patients' data were analyzed (fifty-six [56] in the hydralazine group and fifty-seven [57] in the labet …
Effects of Nifedipine and Labetalol Combined with Magnesium Sulfate on Blood Pressure Control, Blood Coagulation Function, and Maternal and Infant Outcome in Patients with Pregnancy-Induced Hypertension.
Shao Y, Gu S, Zhang X. Shao Y, et al. Comput Math Methods Med. 2022 Oct 13;2022:9317114. doi: 10.1155/2022/9317114. eCollection 2022. Comput Math Methods Med. 2022. PMID: 36277012 Free PMC article. Clinical Trial.
OBJECTIVE: The purpose is to investigate the influence of nifedipine, labetalol, and magnesium sulfate on blood pressure control, blood coagulation, and maternal and infant outcome in those suffering from pregnancy-induced hypertension (PIH). ...As a control, nifedipine co …
OBJECTIVE: The purpose is to investigate the influence of nifedipine, labetalol, and magnesium sulfate on blood pressure control, blo …
An Equivalence Trial Comparing Labetalol and Diltiazem in Controlling Emergence Hypertension after Supratentorial Tumor Surgery.
Sirivanasandha B, Sakaew A, Sutthivaiyakit K, Raksamani K, Waitayawinyu P, Rushatamukayanunt P, Punkla W. Sirivanasandha B, et al. J Med Assoc Thai. 2015 Nov;98(11):1104-11. J Med Assoc Thai. 2015. PMID: 26817181 Clinical Trial.
The expense for labetalol was 1/6 of diltiazem. CONCLUSION: Labetalol has equivalent efficacy to diltiazem. Both drugs used low median dosage giving low incidence of side-effects. Labetalol is a good alternative drug to control hypertensive response during em …
The expense for labetalol was 1/6 of diltiazem. CONCLUSION: Labetalol has equivalent efficacy to diltiazem. Both drugs used lo …
Antihypertensive and metabolic effects of nifedipine and labetalol alone and in combination in primary hypertension.
Ohman KP, Weiner L, von Schenck H, Karlberg BE. Ohman KP, et al. Eur J Clin Pharmacol. 1985;29(2):149-54. doi: 10.1007/BF00547413. Eur J Clin Pharmacol. 1985. PMID: 3908121 Clinical Trial.
Nifedipine increased plasma renin activity (PRA) and urinary aldosterone excretion (uA), whereas labetalol reduced both. During combination therapy, PRA and uA remained unchanged. ...Adverse effects as a rule were well tolerated and were related to the pharmacological effe …
Nifedipine increased plasma renin activity (PRA) and urinary aldosterone excretion (uA), whereas labetalol reduced both. During combi …
Cost effectiveness of labetalol and propranolol in the treatment of hypertension among blacks.
Oster G, Huse DM, Delea TE, Savage DD, Colditz GA. Oster G, et al. J Natl Med Assoc. 1987 Oct;79(10):1049-55. J Natl Med Assoc. 1987. PMID: 3119865 Free PMC article. Review.
Data from these studies suggest that labetalol and propranolol lower diastolic blood pressure among black hypertensive adults by 11.2 mmHg and 8.4 mmHg, respectively. ...For stepped care, annual costs would be $205 and $212 lower for those treated initially with labetal …
Data from these studies suggest that labetalol and propranolol lower diastolic blood pressure among black hypertensive adults by 11.2 …
Comparison of efficacy of labetalol and fentanyl for attenuating reflex responses to laryngoscopy and intubation.
Meftahuzzaman SM, Islam MM, Ireen ST, Islam MR, Kabir H, Rashid H, Uddin MZ. Meftahuzzaman SM, et al. Mymensingh Med J. 2014 Apr;23(2):242-8. Mymensingh Med J. 2014. PMID: 24858149 Clinical Trial.
This prospective, randomized, placebo controlled, double blinded study was designed to compare the efficacy of bolus dose of Labetalol and Fentanyl for attenuating reflex responses to laryngoscopy and intubation. Ninety patients with physical status of ASA I and II were sc …
This prospective, randomized, placebo controlled, double blinded study was designed to compare the efficacy of bolus dose of Labetalol …
482 results